Our Scientific Approach to Curing Diabetes

We’re developing a regenerative approach that reprograms and differentiates a patient’s own cells to restore insulin production. Our unique process begins with a simple urine sample- and ends with a functional, cell-based solution designed to reverse diabetes at its root.

The Process

Step 1: Collecting Cells from Urine. We start with a non-invasive urine sample.

Step 2: Reprogramming/Differentiating into Pancreatic Cells. Using a unique protocol developed by Dr. Noel Moya, PhD, we transform these cells into IPSCs, which will then be differentiated towards insulin-producing beta cells.

Step 3: Subcutaneous Delivery. The differentiated cells are placed in a biocompatible encapsulation device, designed by our co-founder, Dr. Noel Moya, PhD to protect them from immune system attack, and implanted under the skin. Once in place, the cells function like natural pancreatic beta cells, releasing insulin in response to rising glucose levels.

Step 4: Blood Sugar Regulation. These cells will restore your body’s ability to regulate blood sugar naturally, eliminating the need for insulin injections or oral medication.

How This Differs From Existing Treatments

Current treatments manage symptoms. Ours aims to restore lost function.

  • Uses the patient’s own cells (eliminates risk of immune rejection)

  • Does not rely on donors or immunosuppressants

  • Designed for subcutaneous delivery (no major surgery)

  • Target cost: 10–20x less than current cell therapies

Our goal: long-term insulin independence, not lifelong management.

The Science Behind the Science

Scientific Foundations:

  • Developed through over a decade of stem cell research & published scientific work

  • Unique process to differentiate cells into functional beta cells

  • Patent-pending transplantation method enables immune protection and controlled release

  • Validated in vitro and in vivo (glucose-responsive insulin secretion in small animal models)

  • Preparing for preclinical pig trial (Q4 2025)

Research led by Dr. Noel Moya, PhD, one of the few global experts in beta cell differentiation.